<DOC>
	<DOC>NCT00837512</DOC>
	<brief_summary>The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.</brief_summary>
	<brief_title>Insulin Delivery Using Microneedles in Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>≥ 8 years of age &lt;19 years of age Type 1 Diabetes for at least 2 years Uses a conventional, FDAapproved insulin pump for the past year Uses Lispro insulin Mean hemoglobin A1C ≤ 8.5 % for the past year Body mass index ≤ 85th percentile for age Understand and be willing to adhere to the study protocol Type 2 Diabetes Acanthosis nigricans Clinically significant major organ system disease On glucocorticoid therapy Insulin requirement ≥ 150 U/day Illness on the day of the study Cognitive impairment (IQ &lt; 85 or &gt; 2 grades behind ageappropriate grade) Pregnant or breastfeeding (if female).</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>microneedle continuous subcutaneous insulin infusion</keyword>
</DOC>